Technical Analysis for BJDX - Bluejay Diagnostics, Inc.

Grade Last Price % Change Price Change
D 2.63 2.33% 0.06
BJDX closed up 2.33 percent on Tuesday, December 7, 2021, on 7.36 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical BJDX trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Hot IPO Pullback Bullish Swing Setup 2.33%
New 52 Week Low Weakness 2.33%
Outside Day Range Expansion 2.33%
New 52 Week Closing Low Bearish 12.88%
Hot IPO Pullback Bullish Swing Setup 12.88%
New 52 Week Low Weakness 12.88%
Down 3 Days in a Row Weakness 12.88%
Down 4 Days in a Row Weakness 12.88%
Older End-of-Day Signals for BJDX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 13 hours ago
Gap Up Partially Closed about 15 hours ago
Gapped Up (Full) about 15 hours ago
Hot IPO Pullback Entry about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Bluejay Diagnostics, Inc. Description

Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biotechnology Cancer Clinical Medicine Inflammation Allergy Infectious Disease Biomarkers Congestive Heart Failure Chemical Pathology Allergic Conjunctivitis Sepsis Lyme Disease

Is BJDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 6.25
52 Week Low 2.22
Average Volume 2,533,023
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 2.84
Average True Range 0.48
ADX 0.0
+DI 12.92
-DI 37.70
Chandelier Exit (Long, 3 ATRs) 4.82
Chandelier Exit (Short, 3 ATRs) 3.65
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -0.34
MACD Signal Line -0.20
MACD Histogram -0.1424
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.20
Resistance 3 (R3) 3.25 3.10 3.11
Resistance 2 (R2) 3.10 2.96 3.08 3.07
Resistance 1 (R1) 2.87 2.87 2.80 2.82 3.04
Pivot Point 2.72 2.72 2.69 2.70 2.72
Support 1 (S1) 2.49 2.58 2.42 2.44 2.22
Support 2 (S2) 2.34 2.49 2.32 2.19
Support 3 (S3) 2.11 2.34 2.16
Support 4 (S4) 2.06